The Interagency Pain Research Coordinating Committee (IPRCC), the nation’s highest pain policy advisory committee, held its biannual meeting Oct. 23 at the National Institutes of Health (NIH) campus in Bethesda, MD. The IPRCC is the committee that oversaw the development of the National Pain Strategy, as well as the recently released Federal Pain Research Strategy. U.S. Pain Foundation’s National Director of Policy and Advocacy Cindy Steinberg, a member of the IPRCC, was in attendance.
U.S. Pain’s National Director of Policy and Advocacy, Cindy Steinberg, was invited to present the patient perspective at the National Institutes of Health (NIH) 12th Annual Pain Consortium Symposium on May 31 and June 1. Each year, noted researchers working in the field of pain management are invited to present their research findings and an award is given to a junior investigator who has done outstanding pain research.This year, the theme was, “Multidisciplinary Strategies for Pain Management.”
A federal bill two years in the making, the 21st Century Cures Act, was signed into law Dec. 13 by President Obama. U.S. Pain Foundation stood with more than 15 other organizations—including the National Organization for Rare Disorders, Global Genes, and the Genetic Alliance—to support the act. The $6 billion law will expand funding for medical research, invest in mental health resources and combat the opioid drug epidemic.